Linda Pissott Reig, Shareholder in the firm's FDA & Biotechnology practice, talks about the positive impacts of the FDA's recent approval of new Apple Watch Series 4 features that monitor the user's heart. She talks about partnership between technology companies and our government, how consumers will benefit and regulatory evolution within the FDA. Read MobiHealthNews' "Apple's ECG Announcement Was Likely Years in the Making, But Its Timing Was Remarkable."